
Biopharma analytical tech market to reach $4.32 billion by 2031
The global market for biopharmaceutical process analytical technology is set for a rapid expansion, projected to climb from $1.96 billion in 2026 to $4.32 billion by 2031. Driven by a 17.1% annual growth rate, manufacturers are increasingly turning to real-time monitoring to secure product quality and regulatory compliance.



























